FDA reviewing potential heart risk of HIV combo
This article was originally published in Scrip
Executive Summary
The US FDA is reviewing clinical trial data about a "potentially serious" association of abnormal heart rhythms when Roche's Invirase (saquinavir) is combined with Abbott's Norvir (ritonavir).